查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014861

膝关节重组市场：依产品类型、技术、固定方法和最终用户划分－2026-2032年全球市场预测

Knee Reconstruction Market by Product Type, Technology, Fixation, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，膝关节重组市场价值将达到 32.4 亿美元，到 2026 年将成长至 34.6 亿美元，到 2032 年将达到 54.9 亿美元，复合年增长率为 7.82%。

主要市场统计数据
基准年 2025 32.4亿美元
预计年份：2026年 34.6亿美元
预测年份 2032 54.9亿美元
复合年增长率 (%) 7.82%

透过整合临床进展、商业性驱动因素和不断发展的医疗保健服务模式，我们正在为下一代膝关节重组奠定基础。

膝关节重组正处于转折点，临床需求、技术创新和医疗保健系统经济因素在此交汇，重塑医疗设备策略和治疗路径。近年来，植入材料和对位技术的逐步改进，以及术前规划和术中引导的进步，改变了外科医生进行初次手术和重新置换手术的方式。同时，保险公司和医疗服务提供者更加重视基于价值的治疗结果、缩短住院时间以及向门诊治疗的转变，所有这些都影响着医疗设备製造商的采购重点和商业性决策。

机器人技术、向门诊治疗的转变以及对实证医学和供应链韧性日益增长的需求，正在推动膝关节重组领域的变革性变化。

在膝关节重组领域，一系列变革正在发生，这些变革正在改变医疗服务的提供方式以及产品的研发和商业化方式。机器人技术和先进的导航系统正从小众工具发展成为影响植入选择、手术室工作流程和培训需求的整合平台。这些技术正越来越多地与基于云端的规划和分析功能相结合，为追踪治疗结果和迭代改进医疗设备创造了新的机会。

2025 年美国关税措施对采购、供应商合作和临床供应连续性的累积营运和策略影响。

2025年美国关税措施起到了催化剂的作用，促使整个膝关节重组生态系统采取了广泛的营运和战略应对措施。为了应对目的地体系的变化和进口不确定性的增加，原始设备製造商 (OEM) 和零件供应商正在重新评估其采购地点，优先考虑供应商冗余，并加快关于近岸外包和产能多元化的讨论。这些调整并非仅仅旨在降低成本；它们也体现了缩短前置作业时间、减少跨境物流衝击风险以及简化与生产基地相关的监管流程的意图。

透过对技术、最终用户、产品类型和固定方法的详细细分洞察，指导优先顺序和临床引入策略。

精细的市场细分观点揭示了临床实践、技术和购买行为的交汇点，并着重阐述了这些因素如何共同构成机会和风险。基于技术，市场研究将其分为四种模式：电脑辅助导航、传统手动方法、患者客製化器材和机器人辅助。每种模式都对临床工作流程和培训产生独特的影响。电脑辅助导航往往更受那些希望在不彻底改造手术室的情况下逐步提升手术精准度的医疗机构的青睐；而机器人辅助系统则重新定义了资本投资决策，并将一个全面的数位生态系统扩展到单次手术之外。患者特异性器械为将术前影像整合到简化的植入选择流程中提供了契机；而在成本控制和外科医生熟悉度至关重要的情况下，传统手动方法仍然不可或缺。

世界各地在实施、偿还和基础设施发展方面的关键区域观点，正在塑造不同的商业化方法。

区域趋势在塑造膝关节重组技术的普及曲线和商业化策略方面发挥着至关重要的作用。在美洲，完善的医院网路和不断扩大的门诊手术中心容量，催生了对先进导航技术和支援门诊手术过渡的简化植入的需求。该地区的健保报销体係日益注重效率和术后恢復，推动了对能够改善復健指标的设备和数位平台的投资。同时，都市区三级医疗机构和区域医院在临床实践方面的差异，使得针对不同病例复杂程度，需要製定个人化的外科医生参与计划和循证方案。

这提供了企业级的策略洞察，揭示了领先的整形外科公司如何将平台创新、临床证据和适应性经营模式相结合，以实现市场推广。

膝关节重组领域的主要企业正在推行多管齐下的策略，将技术投资、临床证据的累积以及产品上市时间的创新相结合。一些企业专注于平台策略，整合机器人技术、术前规划软体和结果分析，透过耗材和服务的整合交付，与医疗系统建立长期合作关係。另一些企业则优先开发模组化植入组合，以填补特定的临床空白，例如保留骨骼的部分置换术和可降低术中复杂性的可靠重新置换系统。同时，製造商也在投资外科培训学院和导师制项目，以加速安全部署，并累积临床案例，从而支持产品在医院和门诊环境中的广泛应用。

为医疗设备製造商、医疗保健系统和经销商提供切实可行的策略和营运建议，以加快部署速度并增强韧性。

产业领导者应采取一系列切实可行的步骤，将策略意图转化为临床、营运和商业领域的可衡量进展。首先，透过投资于能够减少适应性差异、加速患者康復并显着改善患者报告结果的产品和数位化工具，使研发重点与可证实的临床价值保持一致。其次，建构以外科医生为中心的教育项目，结合模拟、指导和结果回馈，以加速安全应用，同时降低阻碍应用的学习曲线成本。

一套严谨的调查方法，说明一手访谈、二手文献整合和资料检验验证，旨在为决策者提供可靠且可操作的见解。

本研究采用结构化调查方法，结合一手访谈、二手文献整合和系统性资料检验，以确保其可靠性和对决策者的相关性。一手资料包括对骨科医生、医院采购经理、门诊手术中心管理人员和供应链主管的结构化访谈，旨在收集关于技术采纳、临床工作流程和采购标准的第一手观点。除这些定性见解外，本研究还对同行评审的临床文献、监管指导文件和公开的医疗保健系统采购协议进行了二手分析，以阐明实践模式和证据阈值。

为了引领膝关节重组领域，相关人员应协调临床卓越性、营运韧性和实证商业化。

总而言之，膝关节重组正因技术创新、医疗服务模式的变革以及人们对疗效价值日益增长的期望而转变。机器人手术、导航技术和个人化患者规划正从实验阶段走向主流，成为许多高水准医疗机构的常规选择。然而，成功的商业化需要将循证医学证据的产生、外科医生的培训以及营运准备与医院和门诊的实际采购行为相协调。 2025年费用上涨的压力正在加速供应链重组，并重新激发人们对本地采购的兴趣，但区域趋势仍影响着跨区域技术应用的速度和方式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：膝关节重组市场：依产品类型划分

  • 部分膝关节关节重建手术
  • 膝盖大腿关节重建
  • 重新置换关节重建手术
  • 全膝关节置换术

第九章：膝关节重组市场：依技术划分

  • 电脑辅助导航
  • 传统手工方法
  • 患者专用设备
  • 机器人支援

第十章：以固定方式分類的膝关节重组市场

  • 水泥固定型
  • 无水泥
  • 杂交种

第十一章：膝关节重组市场：依最终用户划分

  • 门诊手术中心
  • 医院

第十二章：膝关节重组市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：膝关节重组市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 膝关节重组市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国膝关节重组市场

第十六章：中国膝关节重组市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • ConforMIS, Inc.
  • Corin Group Limited
  • DePuy Synthes, Inc.
  • Exactech, Inc.
  • MicroPort Scientific Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-43470FC60848

The Knee Reconstruction Market was valued at USD 3.24 billion in 2025 and is projected to grow to USD 3.46 billion in 2026, with a CAGR of 7.82%, reaching USD 5.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.24 billion
Estimated Year [2026] USD 3.46 billion
Forecast Year [2032] USD 5.49 billion
CAGR (%) 7.82%

Setting the stage for next-generation knee reconstruction with a clear synthesis of clinical advances, commercial drivers, and evolving care delivery models

Knee reconstruction is at an inflection point where clinical needs, technological innovation, and health system economics converge to reshape device strategy and care pathways. Over recent years, incremental improvements in implant materials and alignment techniques have combined with advances in preoperative planning and intraoperative guidance to alter how surgeons approach primary and revision procedures. Simultaneously, payers and providers have emphasized value-based outcomes, shorter lengths of stay, and the migration of procedures to ambulatory settings, all of which influence procurement priorities and the commercial calculus for device manufacturers.

Against this backdrop, stakeholders require a holistic view that connects device-level innovation with changes in clinical workflow, reimbursement models, and distribution dynamics. Integrating evidence generation, surgeon training programs, and digital tools for implant selection is now a core competency for market participants. With rising attention on patient-reported outcomes and cost-effectiveness, strategic decisions about technology investments and partnership models must be grounded in multidisciplinary insights. Accordingly, this introduction frames the clinical, technological, and commercial drivers that will inform subsequent sections and guides readers toward actionable conclusions that support sustainable growth and improved patient care.

Transformative shifts in knee reconstruction driven by robotics, care migration to ambulatory settings, and heightened demands for evidence and supply chain resilience

The landscape for knee reconstruction is undergoing a set of transformative shifts that are changing how care is delivered and how products are developed and commercialized. Robotics and advanced navigation systems are maturing from niche tools into integrated platforms that influence implant choice, operating room workflows, and training requirements. These technologies are increasingly paired with cloud-based planning and analytics, which create new opportunities for outcome tracking and iterative device improvement.

Concurrently, the shifting locus of care toward ambulatory surgical centers and same-day discharge pathways is prompting manufacturers and health systems to redesign implants and instrumentation for efficiency, sterility management, and rapid turnover. Value-based contracting and outcome-linked procurement place a premium on long-term survivorship data and patient-reported outcomes, which in turn drives investment in registries and post-market evidence generation. In addition, supply chain resilience and regional sourcing strategies are rising on executive agendas, spurred by recent disruptions that highlighted dependency risks. Taken together, these shifts require an adaptive approach: companies that align clinical evidence, surgeon engagement, and operational efficiencies will be best positioned to capture adoption waves and sustain competitive advantage.

Cumulative operational and strategic consequences of 2025 United States tariff measures on sourcing, supplier collaboration, and clinical supply continuity

United States tariff activity in 2025 has functioned as a catalyst for a range of operational and strategic responses across the knee reconstruction ecosystem. In response to altered duty regimes and elevated import unpredictability, original equipment manufacturers and component suppliers have reassessed sourcing footprints, prioritized supplier redundancy, and accelerated conversations about nearshoring and capacity diversification. These adjustments are not solely cost-driven; they also reflect a desire to shorten lead times, reduce exposure to cross-border logistical shocks, and simplify regulatory pathways tied to production locales.

Consequently, procurement teams and device developers have adopted more granular vendor risk assessments and increased emphasis on long-term supplier partnerships that include shared business continuity planning. For hospital systems and ambulatory surgical centers, procurement strategies have shifted toward multi-vendor approaches and increased scrutiny of total landed cost rather than unit price alone, integrating considerations such as inventory buffering, consignment arrangements, and collaboration on demand forecasting. Regulatory compliance and customs documentation have become higher touchpoints in supplier relationships, prompting organizations to invest in trade-compliance capabilities and specialist legal support.

As a result of these pressures, alliances between manufacturers and local contract manufacturers or component partners have become more common, enabling faster responses to demand fluctuations and closer integration of quality management systems. In sum, the cumulative tariff environment in 2025 has accelerated structural changes in sourcing, inventory management, and supplier collaboration that will shape commercial strategies and operational readiness in the near term.

Deep segmentation insights across technology, end user, product type, and fixation approaches to guide prioritization and clinical adoption strategies

A nuanced segmentation view illuminates where clinical practice, technology, and purchasing behavior intersect to shape opportunity and risk. Based on Technology, market is studied across Computer Assisted Navigation, Conventional Manual, Patient Specific Instrumentation, and Robotics Assisted, and each modality presents distinct clinical workflows and training implications. Computer assisted navigation often appeals to centers seeking incremental improvements in alignment without retooling the entire operating room, whereas robotics assisted systems redefine capital investment decisions and bring comprehensive digital ecosystems that extend beyond the single procedure. Patient specific instrumentation creates opportunities to integrate preoperative imaging into a streamlined implant selection pathway, and conventional manual approaches retain relevance where cost containment and surgeon familiarity predominate.

Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals, and this segmentation underscores divergent purchasing cycles, clinical throughput expectations, and sterilization and inventory needs. Hospitals typically manage complex case mixes and prioritize implants that perform across a range of indications, while ambulatory surgical centers seek solutions that optimize turnaround time and enable efficient, high-volume throughput. Based on Product Type, market is studied across Partial Knee Replacement, Patellofemoral Arthroplasty, Revision Knee Replacement, and Total Knee Replacement, which highlights product development pathways: partial and patellofemoral solutions emphasize bone preservation and faster recovery, total knee replacements address broad degenerative disease, and revision systems focus on modularity and complex fixation. Based on Fixation, market is studied across Cemented, Cementless, and Hybrid approaches, each representing different surgeon preferences, patient bone quality considerations, and long-term outcome trade-offs. Collectively, these segmentation lenses guide prioritization of R&D investments, surgeon education strategies, and tailored commercial models for diverse end users and clinical scenarios.

Critical regional perspectives on adoption, reimbursement, and infrastructure readiness shaping differentiated commercialization approaches across global territories

Regional dynamics play a pivotal role in shaping the adoption curve and commercialization strategies for knee reconstruction technologies. In the Americas, strong hospital networks and growing ambulatory surgical center capacity create demand for both advanced navigation and streamlined implants that support outpatient conversion. Reimbursement frameworks in this region increasingly reward efficiency and post-acute outcomes, encouraging investment in devices and digital platforms that demonstrate improved recovery metrics. Meanwhile, clinical practice variability between urban tertiary centers and community hospitals requires tailored surgeon engagement plans and evidence packages that address different caseload complexities.

In Europe, Middle East & Africa, heterogeneous regulatory landscapes and diverse reimbursement environments create an environment where localized go-to-market models are essential. Some countries within the region adopt fast-track pathways for innovative devices, while others emphasize cost containment, requiring flexible pricing and value demonstration. Infrastructure differences across the region also influence adoption timing for robotics and navigation systems, with higher-density tertiary networks piloting advanced platforms that later diffuse into broader hospital systems.

In Asia-Pacific, rapid investment in surgical capacity, expanding middle-class demand for elective orthopedic care, and government-led hospital expansions are driving interest in scalable instrumentation and digital planning tools. Local manufacturing capability and strategic partnerships with regional distributors often accelerate access, while divergent surgeon training needs and procedural volumes demand robust education models. Across all regions, regulatory agility, reimbursement alignment, and distribution excellence remain critical determinants of successful commercialization, and companies that adapt their value propositions to regional priorities will gain traction more quickly.

Strategic company-level insights revealing how leading orthopedic firms combine platform innovation, clinical evidence, and adaptive commercial models to win adoption

Leading companies in the knee reconstruction space are pursuing multifaceted strategies that combine technological investment, clinical evidence generation, and go-to-market innovation. Some organizations are concentrating on platform plays that bundle robotics, preoperative planning software, and outcome analytics, enabling longer-term relationships with health systems through integrated consumable and service offerings. Others prioritize modular implant portfolios that target specific clinical gaps, such as bone-preserving partial replacements or robust revision systems that reduce intraoperative complexity. In parallel, manufacturers are investing in surgeon training academies and proctorship programs to accelerate safe adoption and to generate the clinical narratives that support uptake in both hospitals and ambulatory settings.

Commercially, companies are experimenting with alternative contracting models that align pricing with outcomes or that facilitate capital access for robotics through lease and subscription arrangements. Supply chain strategies increasingly emphasize dual-sourcing, localized manufacturing partnerships, and enhanced inventory transparency to reduce disruption risk. In regulatory and reimbursement arenas, industry participants are accelerating post-market evidence collection and registry participation to demonstrate comparative effectiveness across fixation approaches and product types. Where companies have differentiated, they typically combine clinical partnerships, rigorous outcomes tracking, and flexible commercial models to lower adoption friction and to strengthen customer retention in a rapidly evolving marketplace.

Actionable strategic and operational recommendations for device makers, health systems, and distributors to accelerate adoption while strengthening resilience

Industry leaders should adopt a set of pragmatic actions that translate strategic intent into measurable progress across clinical, operational, and commercial domains. First, align R&D priorities with demonstrable clinical value by investing in products and digital tools that reduce variability in alignment, enhance patient recovery, and enable measurable improvements in patient-reported outcomes. Second, build surgeon-centric education programs that combine simulation, proctoring, and outcomes feedback to accelerate safe adoption while reducing the learning curve costs that inhibit uptake.

Third, reconfigure supply chain and sourcing strategies to prioritize resilience and flexibility: establish alternative suppliers for critical components, explore regional manufacturing partnerships, and implement inventory strategies that smooth demand volatility. Fourth, pursue commercial models that lower adoption barriers for capital-intensive technologies through leasing, bundled services, or outcome-linked contracting, and coordinate these offers with payer-engagement plans that articulate value across the episode of care. Fifth, scale evidence generation by committing to registry participation and structured post-market studies that capture long-term outcomes across fixation types and product variants, because robust data will be decisive in procurement discussions. Lastly, incorporate scenario planning into strategic reviews to anticipate tariff and trade-policy shifts, ensuring that go-to-market plans remain executable under multiple regulatory and economic contingencies. Taken together, these actions will position organizations to capture adoption opportunities while maintaining operational and financial stability.

Robust research methodology describing primary interviews, secondary synthesis, and data triangulation to deliver credible and actionable insights for decision-makers

This research draws on a structured methodology combining primary interviews, secondary literature synthesis, and systematic data validation to ensure reliability and relevance for decision-makers. Primary inputs included structured interviews with orthopedic surgeons, hospital procurement leaders, ambulatory surgical center administrators, and supply chain executives to capture firsthand perspectives on technology adoption, clinical workflows, and purchasing criteria. These qualitative insights were supplemented by secondary analysis of peer-reviewed clinical literature, regulatory guidance documents, and publicly available health system procurement protocols to contextualize practice patterns and evidentiary thresholds.

Data triangulation occurred through cross-referencing interview findings with product approval pathways and published clinical outcome studies, enabling identification of consistent themes and areas of divergence. Attention was paid to temporal relevance by prioritizing the most recent clinical trials, registry reports, and guideline updates, and by validating claims with multiple independent sources when feasible. Limitations of the approach include dependent variability in regional data transparency and evolving policy environments that can change operational assumptions; consequently, scenario-based sensitivity checks and expert workshops were used to interrogate critical uncertainties. Finally, methodological rigor was maintained through internal peer review and iterative refinement of conclusions to ensure actionable and defensible recommendations for industry stakeholders.

Concluding imperatives for stakeholders to align clinical excellence, operational resilience, and evidence-driven commercialization to lead in knee reconstruction

In summary, knee reconstruction is being reshaped by technological innovation, shifting care settings, and heightened expectations for demonstrable value. Robotics, navigation, and patient-specific planning are moving from experimental to mainstream considerations in many high-volume centers, but successful commercialization depends on aligning evidence generation, surgeon training, and operational readiness with the realities of hospital and ambulatory purchasing behaviors. Tariff-related pressures in 2025 have accelerated supply chain reconfiguration and renewed focus on regional sourcing, while regional dynamics continue to dictate the pace and nature of technology uptake across geographies.

Looking ahead, the industry will reward participants who integrate clinical excellence with adaptable commercial models and resilient supply chains. Stakeholders that invest in robust post-market evidence, design pragmatic surgeon education programs, and structure flexible contracting options will reduce adoption friction and create durable value propositions for providers and patients. In closing, strategic clarity, operational discipline, and sustained clinical partnership are the critical levers that will determine which organizations lead the next wave of innovation in knee reconstruction.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Knee Reconstruction Market, by Product Type

  • 8.1. Partial Knee Replacement
  • 8.2. Patellofemoral Arthroplasty
  • 8.3. Revision Knee Replacement
  • 8.4. Total Knee Replacement

9. Knee Reconstruction Market, by Technology

  • 9.1. Computer Assisted Navigation
  • 9.2. Conventional Manual
  • 9.3. Patient Specific Instrumentation
  • 9.4. Robotics Assisted

10. Knee Reconstruction Market, by Fixation

  • 10.1. Cemented
  • 10.2. Cementless
  • 10.3. Hybrid

11. Knee Reconstruction Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Knee Reconstruction Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Knee Reconstruction Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Knee Reconstruction Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Knee Reconstruction Market

16. China Knee Reconstruction Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arthrex, Inc.
  • 17.6. B. Braun Melsungen AG
  • 17.7. ConforMIS, Inc.
  • 17.8. Corin Group Limited
  • 17.9. DePuy Synthes, Inc.
  • 17.10. Exactech, Inc.
  • 17.11. MicroPort Scientific Corporation
  • 17.12. Smith & Nephew plc
  • 17.13. Stryker Corporation
  • 17.14. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL KNEE RECONSTRUCTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL KNEE RECONSTRUCTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATELLOFEMORAL ARTHROPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATELLOFEMORAL ARTHROPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATELLOFEMORAL ARTHROPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REVISION KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REVISION KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REVISION KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COMPUTER ASSISTED NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COMPUTER ASSISTED NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COMPUTER ASSISTED NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CONVENTIONAL MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CONVENTIONAL MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CONVENTIONAL MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATIENT SPECIFIC INSTRUMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATIENT SPECIFIC INSTRUMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATIENT SPECIFIC INSTRUMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY ROBOTICS ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY ROBOTICS ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY ROBOTICS ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GCC KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GCC KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. GCC KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. GCC KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 96. GCC KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. G7 KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. G7 KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. G7 KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. G7 KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 111. G7 KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NATO KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NATO KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NATO KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. NATO KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 116. NATO KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. CHINA KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. CHINA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. CHINA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)